Friday, 20 Apr 2018

You are here

Worldwide Trends in BMI in Children, Adolescents and Adults

Lancet reports on the analysis of 2416 studies, involving 128.9 million persons over 5 years of age shows previously rising trends in children's and adolescents' BMI have plateaued in many high-income countries, but still at high levels. 

Changes in mean BMI in girls between 1975-2016 ranged from virtually no change (−0·01 kg/m2 per decade) in eastern Europe to an increase of 1·00 kg/m2 per decade in central Latin America and an increase of 0·95 kg/m2 per decade in Polynesia and Micronesia.

Changes in mean BMI for boys ranged from a non-significant increase of 0·09 kg/m2 per decade in eastern Europe to an increase of 0·77 kg/m2 per decade in Polynesia and Micronesia.

Mean BMI have hit a plateau in northwestern Europe, high-income English-speaking and Asia-Pacific regions for both sexes, southwestern Europe for boys, and central and Andean Latin America for girls.

However BMI has increased in east and south Asia for both sexes, and southeast Asia for boys.

Global age-standardised prevalence of obesity increased from 0·7% in 1975 to 5·6% in 2016 in girls, and from 0·9% in 1975 to 7·8% in 2016 in boys.

Moderate and severe underweight was highest in India, at 22·7% among girls and 30·7% among boys. In 2016, 75 million girls and 117 million boys worldwide were moderately or severely underweight.

The highest levels of obesity (more than 30%) was seen in girls in Nauru, the Cook Islands, and Palau; and boys in the Cook Islands, Nauru, Palau, Niue, and American Samoa in 2016. Prevalence of obesity was about 20% or more in several countries in Polynesia and Micronesia, the Middle East and north Africa, the Caribbean, and the USA.

IN 2016, 50 million girls and 74 million boys worldwide were obese.


The author has no conflicts of interest to disclose related to this subject

Add new comment

More Like This

The RheumNow Week in Review – Vitamin D Snark Report (4.20.18)

Dr. Jack Cush reviews the news and journal reports from the past week on  A second life for Syk kinase, Vitamin D talk, VTE, regulatory hearings and the Lupus clinic edge.

RheumNow Week in Review - Do you Dig Shingrix? (4.6.2018)

Dr. Jack Cush reviews the news and journal reports from the past week on Highlights includes manpower shortfalls, comorbidities in AA Lupus, certolizumab pregnancy safety, which Shingles vaccine is best and the power of combination biologics in severe refractory  SLE.

"Breakthrough" Drug Designation by the FDA

The current issue of the NEJM reviews the Food and Drug Administration (FDA) “breakthrough therapy” designation that was introduced in 2012 to expedite testing and approval of medications that were intended to treat serious or life-threatening conditions.  This status is granted when preliminary evidence with a new drug suggests substantial benefits over existing therapies for these unfortunate conditions.

ACR Projects Significant Manpower Shortages for 2030

Arthritis & Rheumatology has published the results of the 2015 Workforce Study of Rheumatology Specialists, and estimates a current shortage (demand > supply) of 700 (12.9%) full-time rheumatologists and that this deficit will worsen (102%) to 4133 FTE by 2030.

RheumNow Week in Review -The Temporal Artery Biopsy Letdown (4.6.2018)

Dr. Jack Cush reviews the news and journal reports from the past week on News on the cost of RA care, infections on planes, CV events and Sacroiliitis in IBD, NXP-2 antibodies and calcinosis and rituximab in myositis ILD patients.